Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis

JOURNAL ARTICLE published November 2021 in Cancer Immunology, Immunotherapy

Authors: E. Suazo-Zepeda | M. Bokern | P. C. Vinke | T. J. N. Hiltermann | G. H. de Bock | G. Sidorenkov